Dr. Plante obtained her medical degree from Laval University in 1985 and completed her residency in obstetrics and gynecology at McGill University in 1990. She continued with a 3-year subspecialty in gynecologic oncology at the Memorial Sloan-Kettering Cancer Center in New York in 1993. Since then, she has worked as a gynecologist-oncologist at l’Hôtel-Dieu de Québec.
Dr. Plante is a Professor in the Department of Obstetrics and Gynecology at Laval University. She is head of the oncology-gynecology department and in charge of clinical research at l’Hôtel-Dieu de Québec.
- Plante is best known for her expertise in minimally invasive surgery in the treatment of gynecological cancers, including robot-assisted surgery, the sentinel lymph node technique in gynecological cancers and in surgeries aimed at preserving fertility in young women suffering from cervical cancer, including radical trachelectomy.
- Plante is the principal investigator of a large international, prospective and randomized study led by the Canadian Cancer Trials Group (CCTG) and the Gynecologic Cancer InterGroup (GCIG) (CX-5 or SHAPE study). The study aims to randomize patients with early-stage and low-risk cervical cancer to receive either radical hysterectomy (standard) or simple hysterectomy (studied). More than 700 patients will be randomized in this study.
- In addition, Dr. Plante is particularly interested in oncogenetics related to ovarian cancer. She has been involved in the activities of the oncogenetics department, along with the St-Sacrement Hospital team, since its inception, and is responsible for its ovarian component.
- Co-chair of CCRN (Cervical Cancer Research Network)
- Chair, International Committee, SGO (Society of Gynecologic Oncology)
- Co-chair, Cervix Working Group, CCTG
- Member, Editorial Board, International Journal of Gynecologic Cancer (IJGC) and Journal of Obstetrics and Gynecology of Canada (JOGC)
11, côte du Palais
Canada G1R 2J6
Data not available
- Teo-Fortin, Ly-AnnInternL'Hôtel-Dieu de Québeclyfirstname.lastname@example.org
11 Côte du Palais
11611 (Salle 108)
Canada G1R 0A2
HRT use among women tested for BRCA1/2 mutations following publication of the women's health initiative study results.Journal Article
J Obstet Gynaecol Can, 27 (4), pp. 321; author reply 322, 2005, ISSN: 1701-2163.
Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas.Journal Article
Int J Gynecol Pathol, 24 (2), pp. 138-46, 2005, ISSN: 0277-1691.
Lymph node metastases in low-grade endometrial stromal sarcoma.Journal Article
Gynecol Oncol, 96 (2), pp. 402-6, 2005, ISSN: 0090-8258.
Les enjeux éthiques de l'identification d'une susceptibilité génétique au cancer du sein dans un contexte de recherche clinique intégréeBook Chapter
C, Hervé; BM, Knoppers; PA, Molinari (Ed.): Les pratiques de recherche biomédicale visitées par la bioéthique, pp. 113-136, Paris, Dalloz, 2003, ISBN: 2247050697.
Mercury in Salluit : effects of mercury on oxydative [sic] status and sensorimotor functionsBook Chapter
Synopsis of research conducted under the 2001-2003 Northern Contaminants Program, pp. 73-85, Ottawa, Dept. of Indian Affairs and Northern Development, 2003, 2003.
- Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
- Centre de recherche sur le cancer, Subvention, Institutionnel - BDR, BDR - Centres de recherche reconnus, from 1996-05-01 to 2022-06-13
Recently finished projects
- Randomized trial comparing radical hysterectomy and pelvic node dissection vs simple hysterectomy and pelvic node dissection in patients with low risk cervical cancer defined as lesions measuring less than 2 cm with less than 50% stromal in, Subvention, Instituts de recherche en santé du Canada, Subvention de fonctionnement, from 2012-03-31 to 2020-03-31